Report post

Does Regeneron Pharmaceuticals Inc (regn) pay a dividend?

No significant news for in the past two years. REGN is not currently paying a regular dividend. View the latest Regeneron Pharmaceuticals Inc. (REGN) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Why are Sanofi and Regeneron shares trading higher?

Sanofi, Regeneron shares pop more than 6% after data shows asthma drug Dupixent may also treat COPD Coinbase’s stock tumbles after SEC warning, and other stocks on the move Why Regeneron Pharmaceuticals And Sanofi Shares Are Trading Higher Today Fiscal Q4 2022 ended 12/31/22. Reported on 2/3/23.

What is Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP.

The World's Leading Crypto Trading Platform

Get my welcome gifts